Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial
Main Authors: | Ueda, Akira, Hosokawa, Ayumu, Ogawa, Kohei, Yoshita, Hiroki, Ando, Takayuki, Kajiura, Shinya, Fujinami, Haruka, Kawai, Kengo, Nishikawa, Jun, Tajiri, Kazuto, Minemura, Masami, Sugiyama, Toshiro |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656890/ |
Similar Items
-
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study
by: Kajiura, Shinya, et al.
Published: (2015) -
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
by: Ando, Takayuki, et al.
Published: (2015) -
Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir
by: Baba, Hayato, et al.
Published: (2016) -
A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab
by: Tajiri, Kazuto, et al.
Published: (2013) -
Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study
by: Ogawa, Kohei, et al.
Published: (2012)